Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Board/Management Information 2025

Mar 30, 2025

62573_rns_2025-03-30_2ac79bc6-99c4-499d-a301-a21388202820.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [162 x 79] intentionally omitted <==

March 30, 2025

The Manager, Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: PANACEABIO

BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349

Sub: Intimation of completion of tenure of Mrs. Manjula Upadhyay as an Independent Director

Dear Sir / Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we would like to inform you that Mrs. Manjula Upadhyay (DIN: 07137968), Independent Director of the Company has completed her second and final term of 5 (five) consecutive years as Independent Director on March 29, 2025 and consequently she has ceased to be the director of the Company. Accordingly, she has also ceased to be the Chairperson / member of the Committees of the Board of Directors of the Company.

Mrs. Manjula Upadhyay will however continue to be non-executive independent director of the Company’s material wholly-owned subsidiary company, Panacea Biotec Pharma Limited.

The Board of Directors and the Management of the Company express deep appreciation and gratitude to the aforesaid director for her extensive contribution and guidance towards the business growth of the Company.

The details required to be disclosed under Regulation 30 of the SEBI LODR Regulations read along with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed herewith as Annexure - A .

This is for your kind information and record please.

Thanking you, Sincerely yours, For Panacea Biotec Limited

Vinod Digitally signed by Vinod Goel Date: Goel 2025.03.30 07:53:15 +05'30'

Vinod Goel Group CFO and Head Legal & Company Secretary

Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]

==> picture [162 x 79] intentionally omitted <==

Annexure - A

S.
No.
Particulars Description
1. Reason for change viz. appointment,
reappointment, resignation, removal,
death or otherwise
Mrs. Manjula Upadhyay has ceased to be
Independent Director upon completion
of her 2ndand final tenure as an
Independent Director of the Company
2. Date of~~appointment / re-appointment /~~
cessation (as applicable)~~& term of~~
~~appointment/re- appointment~~
March 29, 2025
3. Brief profile, in case of appointment Not Applicable
4. Disclosure of relationships between
directors (in case of appointment of a
director)
Not Applicable

Digitally signed Vinod by Vinod Goel Date: 2025.03.30 Goel 07:53:45 +05'30'

Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]